Written by Admin | Nov 20, 2019
Sanofi is launching a companywide project to incorporate its real-world data platform with Aetion’s analytics system to better develop studies capable of standing up to regulatory requirements. The drugmaker’s internal data platform, named DARWIN, compiles and analyzes de-identified data gathered from hundreds of millions of patients, according to the company. In one project, Sanofi is currently working with Sema4 on a five-year, digital longitudinal study of about 1,200 asthma patients.
Read More